中国组织工程研究

中国组织工程研究 ›› 2011, Vol. 15 ›› Issue (14): 2619-2623.doi: 10.3969/j.issn.1673-8225.2011.14.033

• 干细胞学术探讨 stem cell academic discussion • 上一篇    下一篇

人骨髓间充质干细胞的衰老机制及其“永生化”技术

黄  炜，吕安林，刘博武，候  婧，李  垚，燕学波   

  1. 解放军第四军医大学西京医院心血管内科，陕西省西安市  710032
  • 收稿日期:2010-11-24 修回日期:2010-12-16 出版日期:2011-04-02 发布日期:2013-11-02
  • 通讯作者: 吕安林，副教授，解放军第四军医大学西京医院心血管内科，陕西省西安市 710032 lvanlin@yahoo.com.cn
  • 作者简介:黄炜★，女，1986年生，陕西省宝鸡市人，汉族，解放军第四军医大学第一附属医院在读硕士，主要从事骨髓间充质干细胞治疗心力衰竭方面的基础研究。 huangwei0521@126.com

Senescence mechanism and immortalization of human bone marrow mesenchymal stem cells

Huang Wei, Lü An-lin, Liu Bo-wu, Hou Jing, Li Yao, Yan Xue-bo   

  1. Department of Cardiology, Xijing Hospital, Fourth Military Medical University of Chinese PLA, Xi’an  710032, Shaanxi Province, China
  • Received:2010-11-24 Revised:2010-12-16 Online:2011-04-02 Published:2013-11-02
  • Contact: Lü An-lin, Associate professor, Department of Cardiology, Xijing Hospital, Fourth Military Medical University of Chinese PLA, Xi’an 710032, Shaanxi Province, China lvanlin@yahoo.com.cn
  • About author:Huang Wei★, Studying for master’s degree, Department of Cardiology, Xijing Hospital, Fourth Military Medical University of Chinese PLA, Xi’an 710032, Shaanxi Province, China huangwei0521@126.com

PDF

651

摘要：

背景：人类骨髓间充质干细胞由于其自身特性，被认为是最有潜力修复坏死心肌的干细胞，并已成为心肌组织工程研究的热点。
目的：回顾分析人类骨髓间充质干细胞的衰老机制及根据这些机制建立的人类骨髓间充质干细胞永生化方法。
方法：由第一作者检索1990/2010 PubMed数据库、万方数据库及Springer、Science Direct数据库有关骨髓间充质干细胞衰老机制及其永生化方法等方面的文献。
结果与结论：骨髓间充质干细胞在体外培养传代过程中存在着细胞老化、干细胞样特征丢失的现象，阻碍了其在临床的广泛应用。通过对p53-p21及p16-pRb等信号通路细胞衰老分子机制的深入了解，研究者们试图建立永生化的骨髓间充质干细胞，包括将HPV16 E6E7蛋白的基因转入人骨髓间充质干细胞建立的KP细胞系，或将端粒末端转移酶反转录酶的片段 phTERT -IRES2-EGFP转染入KP细胞，建立3A6细胞系等方法，均在一定程度上延长了骨髓间充质干细胞寿命。但由于利用病毒载体进行基因转染方法带来的基因重组和插入突变等风险及细胞的固有抗病毒反应导致转染成功率较低，因而大量研究集中在了寻找非基因干涉方法上，建立标准化的永生化骨髓间充质干细胞的方法有待进一步研究。

关键词: 骨髓间充质干细胞, 心肌细胞, 衰老, 信号通路, 永生化

Abstract:

BACKGROUND: Human bone marrow mesenchymal stem cells (hBMSCs) due to its property are considered one of the most promising stem cell for regeneration of the injured myocardiocytes, and have become the hot point for the study of myocardial tissue engineering.
OBJECTIVE: To retrospectively analyze senescence mechanism of hBMSCs and to establish immortalized method of hBMSCs according to these mechanisms.
METHODS: The first author retrieved PubMed Database, Wanfang Database, Springer and Science Direct Database for articles on senescence mechanism of hBMSCs and the immortalized method published from 1990 to 2010.
RESULTS AND CONCLUSION: The senescence and loss of the stem cell property of BMSCs were found during the cell cultivation in vitro, which profoundly hinders clinical application of hBMSCs. In light of the mechanism of senescence including p53-p21 and p16-pRb, researchers have put intensive effort in finding ways to build up immortalized hBMSCs; methods for immortalization involving KP cells that transfect HPV16 E6E7 gene into BMSCs or 3A6 cells that both HPV16 E6E7 gene and phTERT -IRES2-EGFP are transfected into hBMSCs. Methods above had prolonged the BMSC survival. However, DNA transfection-based methodologies entail some risk of genomic recombination or insertional mutagenesis as well as innate antiviral responses. Thus, the success rate of transfection is low. The search for ways to avoiding senescence without incurring genetic change has become the focus of intense research effort. Standard methods for building up immortalized BMSCs require further study.

中图分类号: